Gault Cheryl
SEC insider (Form 3/4/5 filer). CIK 0001839046. Chief Operating Officer at Rapport Therapeutics, Inc. (RAPP). 14 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in BOSTON, MA.
Companies Gault Cheryl has filed insider reports for
- Rapport Therapeutics, Inc. (RAPP): Officer, Chief Operating Officer
Gault Cheryl
CIK: 0001839046
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Rapport Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Sep 30, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect2.1K shares at avg. $33.76$70K - Sep 30, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect7.9K shares at avg. $33.04$262K - Jun 30, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect3.3K shares at avg. $42.17$140K - Jun 30, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect1K shares at avg. $43.15$43K - Jun 30, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect3.8K shares at avg. $41.39$157K - Jun 30, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect1.9K shares at avg. $40.09$76K - Mar 5, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect2K shares at avg. $28.93$58K - Feb 2, 2026RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
132K shares- - Nov 26, 2025RAPP
Rapport Therapeutics, Inc.
SaleDirect5K shares at avg. $30.10$150K - Nov 26, 2025RAPP
Rapport Therapeutics, Inc.
ExerciseDirect5K shares at avg. $1.80$9K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 2,075 | $33.76 | $70,043 | Direct |
| Sep 30, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 7,925 | $33.04 | $261,813 | Direct |
| Jun 30, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 3,308 | $42.17 | $139,506 | Direct |
| Jun 30, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 1,000 | $43.15 | $43,155 | Direct |
| Jun 30, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 3,792 | $41.39 | $156,964 | Direct |
| Jun 30, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 1,900 | $40.09 | $76,174 | Direct |
| Mar 5, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 2,014 | $28.93 | $58,265 | Direct |
| Feb 2, 2026 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 132,000 | - | - | Direct |
| Nov 26, 2025 | RAPP Rapport Therapeutics, Inc. | Sale | 5,000 | $30.10 | $150,487 | Direct |
| Nov 26, 2025 | RAPP Rapport Therapeutics, Inc. | Exercise | 5,000 | $1.80 | $9,000 | Direct |
1-10 of 14 transactions